
Hadasit Bio-Holdings Ltd
Share · IL0010954050 (OTC)
No Price
Company Profile for Hadasit Bio-Holdings Ltd Share
Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It primarily focuses on the therapeutic areas, including oncology, regenerative medicine, and inflammatory disease. The company offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. Hadasit Bio-Holdings Ltd was founded in 2005 and is based in Jerusalem, Israel.
Latest AI Analyses of Hadasit Bio-Holdings Ltd
No AI threads available for this company yet.
Company Data
Name Hadasit Bio-Holdings Ltd
Company Hadasit Bio-Holdings Ltd
Website
https://www.hbl.co.il
Primary Exchange
UTC
ISIN IL0010954050
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Yuval Adar
Country Israel
Currency USD
Employees 0,0 T
Address Jerusalem Bio-Park, 91120 Jerusalem
IPO Date 2010-10-27
Dividends from 'Hadasit Bio-Holdings Ltd'
| Ex-Date | Dividend per Share |
|---|---|
| 06.02.2019 | 0,59 ILS |
| 07.02.2019 | 0,16 USD |
Stock Splits
| Date | Split |
|---|---|
| 11.08.2016 | 1:10 |
| 23.12.2009 | 833:500 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | HSITF |
More Shares
Investors who hold Hadasit Bio-Holdings Ltd also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.



